Similar articles

• Fluticasone propionate and mometasone furoate have a low risk of contact sensitization.

  Wilkinson SM, Beck MH. Wilkinson SM, et al. Contact Dermatitis. 1996 May;34(5):365-6. doi: 10.1111/j.1600-0536.1996.tb02226.x. Contact Dermatitis. 1996. PMID: 8807234 No abstract available.
• Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.

  Affrime MB, Banfield C, Nolop K. Affrime MB, et al. Eur Respir J. 2001 Jul;18(1):246. doi: 10.1183/09031936.01.00206701. Eur Respir J. 2001. PMID: 11510799 No abstract available.
• Mometasone furoate lotion once daily versus triamcinolone acetonide lotion twice daily in psoriasis.

  Swinehart JM, Barkoff JR, Dvorkin D, Fisher G, Peets E. Swinehart JM, et al. Int J Dermatol. 1989 Dec;28(10):680-1. doi: 10.1111/j.1365-4362.1989.tb02442.x. Int J Dermatol. 1989. PMID: 2687182 Clinical Trial. No abstract available.
• The new corticosteroids: are they effective and safe?

  Degreef H, Dooms-Goossens A. Degreef H, et al. Dermatol Clin. 1993 Jan;11(1):155-60. Dermatol Clin. 1993. PMID: 8435911 Review.
• Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis.

  Davies RJ, Nelson HS. Davies RJ, et al. Clin Ther. 1997 Jan-Feb;19(1):27-38; discussion 2-3. doi: 10.1016/s0149-2918(97)80070-7. Clin Ther. 1997. PMID: 9083706 Review.